Holen Sie sich die Stockscreener-App
11.01
0.99%
-0.11
Schlusskurs vom Vortag:
$11.12
Offen:
$11.12
24-Stunden-Volumen:
15,084
Relative Volume:
0.37
Marktkapitalisierung:
$44.52M
Einnahmen:
$147.75M
Nettoeinkommen (Verlust:
$-284.23M
KGV:
-3.7577
EPS:
-2.93
Netto-Cashflow:
$-317.54M
1W Leistung:
-0.99%
1M Leistung:
-6.14%
6M Leistung:
+32.09%
1J Leistung:
+38.10%
1-Tages-Spanne:
$11.00
$11.27
1-Wochen-Bereich:
$10.50
$11.31
52-Wochen-Spanne:
$4.50
$21.94
Fibrogen Inc Stock (FGEN) Company Profile
Firmenname
Fibrogen Inc
Sektor
Branche
Telefon
415-978-1200
Adresse
350 BAY STREET, SAN FRANCISCO, CA
Vergleichen Sie FGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FGEN
Fibrogen Inc
|
11.01 | 44.97M | 147.75M | -284.23M | -317.54M | -2.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-06-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-26 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-06-26 | Herabstufung | Stifel | Buy → Hold |
| 2023-06-26 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-02 | Hochstufung | Stifel | Hold → Buy |
| 2023-01-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-09-22 | Herabstufung | Goldman | Neutral → Sell |
| 2021-08-20 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2021-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-07-16 | Herabstufung | Stifel | Buy → Hold |
| 2021-04-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-04-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-03-31 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-02 | Herabstufung | Jefferies | Buy → Hold |
| 2021-02-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-26 | Eingeleitet | Raymond James | Underperform |
| 2020-07-10 | Fortgesetzt | Stifel | Buy |
| 2020-05-01 | Eingeleitet | Cowen | Market Perform |
| 2020-04-27 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-05-29 | Fortgesetzt | Goldman | Neutral |
| 2019-05-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-04-12 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-02-11 | Fortgesetzt | Stifel | Buy |
| 2018-12-19 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-08-08 | Bestätigt | Leerink Partners | Outperform |
| 2017-08-08 | Bestätigt | Stifel | Buy |
| 2017-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2017-07-11 | Eingeleitet | Jefferies | Buy |
| 2016-02-11 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2016-01-21 | Eingeleitet | Credit Suisse | Neutral |
| 2015-12-04 | Eingeleitet | Citigroup | Buy |
| 2015-09-23 | Eingeleitet | Lake Street | Hold |
| 2015-07-29 | Eingeleitet | Citigroup | Buy |
| 2015-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2014-12-09 | Eingeleitet | Stifel | Buy |
Alle ansehen
Fibrogen Inc Aktie (FGEN) Neueste Nachrichten
Will earnings trigger a reversal in FibroGen Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Chart based exit strategy for FibroGen Inc.Portfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Backtesting results for FibroGen Inc. trading strategies2025 Investor Takeaways & Verified Trade Idea Suggestions - newser.com
How to read the order book for FibroGen Inc.Portfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
FibroGen (NASDAQ: FGEN) sets Q3 results; 5:00 PM ET conference call Monday - Stock Titan
What does recent volatility data suggest for FibroGen Inc.2025 Price Targets & Community Consensus Picks - newser.com
Should you hold or exit FibroGen Inc. nowQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Is FibroGen Inc. stock ready for a breakoutWeekly Market Report & Free High Return Stock Watch Alerts - newser.com
Building trade automation scripts for FibroGen Inc.Weekly Trend Summary & Safe Capital Investment Plans - newser.com
Is FibroGen Inc. reversing from oversold territoryTrade Volume Report & High Conviction Buy Zone Picks - newser.com
What to expect from FibroGen Inc. in the next 30 days2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com
Forecasting FibroGen Inc. price range with options dataJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
What hedge fund activity signals for FibroGen Inc. stock2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Technical signs of recovery in FibroGen Inc.July 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
Can FibroGen Inc. stock outperform in 2025 bull marketEarnings Trend Report & Reliable Entry Point Trade Alerts - newser.com
How to integrate FibroGen Inc. into portfolio analysis toolsGlobal Markets & Risk Adjusted Swing Trade Ideas - newser.com
Can FibroGen Inc. stock sustain institutional interestJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Why FibroGen Inc. stock attracts global investorsTrend Reversal & Precise Buy Zone Identification - newser.com
Can FibroGen Inc. (1FG0) stock reach $200 price target2025 Price Action Summary & Community Driven Trade Alerts - newser.com
What analysts say about FibroGen Inc 1FG0 stockShort-Term Trading Alerts & Minimal Capital Growth Plans - earlytimes.in
Is FibroGen Inc. stock attractive for hedge fundsEarnings Risk Report & AI Driven Stock Reports - newser.com
Is FibroGen Inc. (1FG0) stock expanding market penetrationAnalyst Upgrade & Reliable Intraday Trade Alerts - newser.com
Finanzdaten der Fibrogen Inc-Aktie (FGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):